<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and second round of treatment were maintained for the measurement of tumor size. (A) (B) Measurement of tumor volumes at 3 weeks after treatment. (C) (D) Measurement of weights of isolated tumor mass at 3 weeks after treatment. <i>* p</i><0.05, ** <i>p</i><0.01, and *** <i>p</i><0.001 by one-way ANOVA. Arrows represent the time points of treatment. Asterisks represent statistical significance compared to PBS. Asterisks on brackets represent significance in difference between the two groups. (E) TUNEL staining of tumor tissues. Green, apoptotic cells; Blue, nucleus. PBS, phosphate-buffered saline; CPT, cisplatin; CET, cetuximab; CPT+CET, cisplatin plu...
<p>(<b>A</b>) Treatment of nude mice bearing human breast cancer xenografts with BT-474. Injection o...
<p>(A) Measurement of body weight in nude mice once per week. (B) Measurement of tumor volume in nud...
<p>Summary of mean body weights of mice at the beginning of treatment and at the termination of the ...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>At 72 h after PDT, the average volume of treated tumors was significantly different than untreate...
<p>Axial T2W images of a representative mouse in the control group (first row) and a mouse in the tr...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>A, RTV measurements in survival study comparing the effect of different treatments on tumor devel...
<p>35 nude mice were randomly divided into 4 groups and treated with vector, 16.5/kg/d resveratrol, ...
<p>Relative tumor volume was calculated by dividing post-treatment tumor volume by pre-treatment tum...
<p>(A) Tumor growth was determined by bioluminescence (left) and SPECT-CT imaging (middle). Only the...
<p>Growth of tumors following TP202377-treatment of A2780 (top panel), A2780/Top216 (mid panel) and ...
<p>A. Tumor volume (mm<sup>3</sup>) for each individual mouse, as measured from T<sub>2</sub>W MRI i...
<p>Tumor-bearing mice were treated for nine consecutive days with doxorubicin (2 mg/kg), and tumor g...
<p>Mean tumor volume for all surviving mice at days 10, 15, 20, and 25 post-treatment. Mann-Whitney ...
<p>(<b>A</b>) Treatment of nude mice bearing human breast cancer xenografts with BT-474. Injection o...
<p>(A) Measurement of body weight in nude mice once per week. (B) Measurement of tumor volume in nud...
<p>Summary of mean body weights of mice at the beginning of treatment and at the termination of the ...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>At 72 h after PDT, the average volume of treated tumors was significantly different than untreate...
<p>Axial T2W images of a representative mouse in the control group (first row) and a mouse in the tr...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>A, RTV measurements in survival study comparing the effect of different treatments on tumor devel...
<p>35 nude mice were randomly divided into 4 groups and treated with vector, 16.5/kg/d resveratrol, ...
<p>Relative tumor volume was calculated by dividing post-treatment tumor volume by pre-treatment tum...
<p>(A) Tumor growth was determined by bioluminescence (left) and SPECT-CT imaging (middle). Only the...
<p>Growth of tumors following TP202377-treatment of A2780 (top panel), A2780/Top216 (mid panel) and ...
<p>A. Tumor volume (mm<sup>3</sup>) for each individual mouse, as measured from T<sub>2</sub>W MRI i...
<p>Tumor-bearing mice were treated for nine consecutive days with doxorubicin (2 mg/kg), and tumor g...
<p>Mean tumor volume for all surviving mice at days 10, 15, 20, and 25 post-treatment. Mann-Whitney ...
<p>(<b>A</b>) Treatment of nude mice bearing human breast cancer xenografts with BT-474. Injection o...
<p>(A) Measurement of body weight in nude mice once per week. (B) Measurement of tumor volume in nud...
<p>Summary of mean body weights of mice at the beginning of treatment and at the termination of the ...